Delivery Order SPE2DE21D7020-SPE2D625F6GQ2
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $10,349.06 by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 7.0 X 120MM 150CM medical devices. The contract, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, utilizes fixed-price pricing with economic price adjustment and was not set aside for any specific business type. The place of...
- This delivery order, awarded on July 18, 2025, provides Boston Scientific Corp with a fixed-price contract valued at $3,948.58 for the supply of Ranger Global DCB OTW 6.0 x 40mm 80cm medical devices. The award was made by the Defense Health Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring medical equipment and supplies for Department of Defense healthcare operations. The contract utilizes economic price adjustment terms and is scheduled for completion...
- Boston Scientific Corp has been awarded a delivery order valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain for the procurement of Ranger Global DCB OTW 6.0 x 100mm 135cm medical devices. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of September 22, 2025. The award was made without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace....
- The U.S. government has awarded a delivery order contract to Boston Scientific Corp, a global medical technology company, for the provision of RANGER GLOBAL DCB OTW 4.0 X 100MM 135CM medical devices. The contract, with a ceiling value of $7,317.95, is a fixed-price agreement with economic price adjustment, and is being administered by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of January 24, 2025. Boston Scientific Corp, headquartered in Marlborough,...
- Boston Scientific Corp has been awarded a delivery order valued at $11,136.66 by the Defense Health Agency's Medical Supply Chain division for the provision of Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) devices measuring 6.0 x 200mm with a 150cm length. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. The award was made without a small business set-aside, allowing...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for RANGER GLOBAL DCB OTW 4.0 x 120MM 150CM medical devices, with a ceiling value of $30,554.50 under a fixed-price contract with economic price adjustment provisions. The award was made on August 4, 2025, with an ultimate completion date of August 11, 2025. This is an open competition contract with no set-aside designation, and the place of performance is Boston Scientific's facility...
- Boston Scientific Corp has been awarded a delivery order valued at $2,981.31 for RANGER GLOBAL DCB (drug-coated balloon) 7.0 x 150mm devices, 150cm in length, under a fixed price contract with economic price adjustment provisions. The award, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is funded through the Defense Health Agency's Medical Supply Chain and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. This delivery order was not...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order contract valued at $1,974.29 by the Defense Health Agency's Medical Supply Chain on July 2, 2025, with an ultimate completion date of July 10, 2025. The contract, issued without a set-aside designation, covers the procurement of a Ranger Global DCB (drug-coated balloon) OTW (over-the-wire) 7.0 x 60mm 80cm medical device. The contract employs fixed-price...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $44,802.45 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. The contract, designated as RANGER GLOBAL DCB OTW 4.0 X 60MM 80CM, represents a specialized medical device procurement with an ultimate completion date of September 5, 2025. The award is not set aside for any specific business classification and will be...
- The U.S. Defense Logistics Agency (DLA) awarded a fixed-price delivery order contract valued at $17,754.09 to Boston Scientific Corp for the supply of 4,566,174,119 RANGER GLOBAL DCB OTW 6.0 X 80MM 135CM medical devices. This order was placed under a larger indefinite delivery/indefinite quantity (IDIQ) contract with Boston Scientific. The contract has an ultimate completion date of October 29, 2024 and does not utilize a set-aside designation. Boston Scientific, a leading manufacturer of...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F6GQ2Delivery Order
Boston Scientific Corp has been awarded a delivery order valued at $10,060.61 for Ranger Global DCB OTW 5.0 x 40mm 135cm medical devices under a fixed-price contract with economic price adjustment provisions. The award, issued on July 11, 2025, with an ultimate completion date of July 18, 2025, will be performed at Boston Scientific's facilities in Marlborough, Massachusetts. This delivery order was issued without set-aside restrictions, allowing Boston Scientific to compete openly in the federal marketplace. The contract is funded through the Defense Health Agency's Medical Supply Chain division, a component of the Department of Defense responsible for supplying advanced medical technologies to military healthcare systems and veterans' facilities. The Ranger Global DCB (drug-coated balloon) device represents Boston Scientific's continued role as a critical supplier of specialized cardiovascular intervention equipment to federal healthcare agencies. As a global medical technology leader headquartered in Massachusetts, Boston Scientific maintains an extensive portfolio of federal contracts with the Defense Health Agency, Veterans Affairs, and Defense Logistics Agency, providing cardiovascular devices, stents, catheters, and other advanced medical technologies. This delivery order demonstrates the company's ongoing capability to rapidly fulfill federal healthcare procurement requirements through established indefinite delivery vehicles and blanket purchase agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 7/11/25 |